Literature DB >> 23571591

Genomics in medicine: maturation, but not maturity.

W Gregory Feero.   

Abstract

Mesh：

Year:  2013        PMID： 23571591     DOI： 10.1001/jama.2013.3818

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Decision role preferences for return of results from genome sequencing amongst young breast cancer patients.

Authors:  Cindy B Matsen; Sarah Lyons; Melody S Goodman; Barbara B Biesecker; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2018-08-04

2.  Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable.

Authors:  Sean P David; Samuel G Johnson; Adam C Berger; W Gregory Feero; Sharon F Terry; Larry A Green; Robert L Phillips; Geoffrey S Ginsburg
Journal:  Ann Fam Med       Date:  2015 Jul-Aug       Impact factor: 5.166

3.  The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.

Authors:  Arnaud Pagès; Stéphanie Foulon; Zhaomin Zou; Ludovic Lacroix; François Lemare; Thierry de Baère; Christophe Massard; Jean-Charles Soria; Julia Bonastre
Journal:  Genet Med       Date:  2016-12-01       Impact factor: 8.822

4.  Unlocking sociocultural and community factors for the global adoption of genomic medicine.

Authors:  Lynsey Chediak; Nicola Bedlington; Ayesha Gadson; Alastair Kent; Aiedah Abdul Khalek; Luke Rosen; Malisa Rust; Mohd Farooq Shaikh; Meng Yoe Tan; Samuel Agyei Wiafe; Gareth Baynam; Charles A Steward
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.123

5.  Communication of genetic test results to family and health-care providers following disclosure of research results.

Authors:  Kristi D Graves; Pamela S Sinicrope; Mary Jane Esplen; Susan K Peterson; Christi A Patten; Jan Lowery; Frank A Sinicrope; Sandra K Nigon; Joyce Borgen; Sherri Sheinfeld Gorin; Louise A Keogh; Noralane M Lindor
Journal:  Genet Med       Date:  2013-10-03       Impact factor: 8.822
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.